Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • February
  • Page 7
skye-links-cb1-wegovy-combo-to-223%-weight-loss-after-a-year-in-extension-of-failed-ph.-2-study
Posted inBiotechnology

Skye links CB1-Wegovy combo to 22.3% weight loss after a year in extension of failed ph. 2 study

February 2, 2026
Skye Bioscience has published 52-week data on its investigational obesity drug combination, linking the cocktail to 22.3% total weight loss as…
Read More
roche’s-return-to-rna-continues-with-$1.7b-deal-for-sanegene-program
Posted inBiotechnology

Roche’s return to RNA continues with $1.7B deal for Sanegene program

February 2, 2026
Roche is continuing its return to the RNA space by paying $200 million for the worldwide license to one of…
Read More
a-month-after-alcon-deal-fell-through,-staar-surgical-searches-for-next-ceo-and-names-interim-leaders
Posted inMedical Technology

A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders

February 2, 2026
Staar Surgical has endured a whirlwind start to the New Year with a rejected takeover deal and the loss of…
Read More
unraveling-genome-growth-in-acyclania-tenebrosa
Posted inBiotechnology

Unraveling Genome Growth in Acyclania tenebrosa

February 2, 2026
In a groundbreaking study published in BMC Genomics, researchers have delved into the genomic landscape of Acyclania tenebrosa, a noctuid…
Read More
modified-folfirinox-plus-nivolumab-in-pancreatic-cancer-trial
Posted inBiotechnology

Modified FOLFIRINOX Plus Nivolumab in Pancreatic Cancer Trial

February 2, 2026
In a groundbreaking advancement in the treatment of pancreatic ductal adenocarcinoma (PDAC), a notoriously aggressive and deadly form of cancer,…
Read More
sanofi’s-troubled-gcs-inhibitor-fails-phase-3-fabry-trial-but-scores-in-gaucher-disease
Posted inBiotechnology

Sanofi’s troubled GCS inhibitor fails phase 3 Fabry trial but scores in Gaucher disease

February 2, 2026
Sanofi’s pipeline features a number of once-hyped candidates that are struggling to deliver in the clinic, and the latest mixed…
Read More
circulating-progenitor-cells-detect-and-repair-aberrant-cells
Posted inBiotechnology

Circulating Progenitor Cells Detect and Repair Aberrant Cells

February 2, 2026
In a groundbreaking advancement that could profoundly impact the field of regenerative medicine and the management of pathological bone formation,…
Read More
enhancing-tomato-seed-germination-with-whey-treatment
Posted inBiotechnology

Enhancing Tomato Seed Germination with Whey Treatment

February 2, 2026
In recent years, the search for sustainable agricultural practices has intensified, driving researchers to explore innovative solutions to improve crop…
Read More
mme-identified-as-key-target-of-notoginsenoside-r1
Posted inBiotechnology

MME Identified as Key Target of Notoginsenoside R1

February 2, 2026
In a groundbreaking study, researchers have unveiled critical insights into diabetic nephropathy, a significant complication in diabetes that can lead…
Read More
marital-status-influences-follicular-lymphoma-survival-rates
Posted inBiotechnology

Marital Status Influences Follicular Lymphoma Survival Rates

February 2, 2026
Recent research has unveiled intriguing insights into social determinants affecting health outcomes, specifically focusing on the relationship between marital status…
Read More

Posts pagination

Previous page 1 … 5 6 7 8 9 … 13 Next page

Privacy Policy    Terms

Scroll to Top